{
    "2020-11-11": [
        [
            {
                "time": "",
                "original_text": "华大基因(300676)2020年三季报点评：新冠检测试剂需求持续旺盛 常规业务逐步恢复",
                "features": {
                    "keywords": [
                        "华大基因",
                        "三季报",
                        "新冠检测试剂",
                        "需求旺盛",
                        "常规业务",
                        "逐步恢复"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}